287 related articles for article (PubMed ID: 32266567)
1. Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial.
Lalla RV; Solé S; Becerra S; Carvajal C; Bettoli P; Letelier H; Santini A; Vargas L; Cifuentes A; Larsen F; Jara N; Oyarzún J; Feinn R; Bustamante E; Martínez B; Rosenberg D; Galván T
Support Care Cancer; 2020 Dec; 28(12):5871-5879. PubMed ID: 32266567
[TBL] [Abstract][Full Text] [Related]
2. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
Trotti A; Garden A; Warde P; Symonds P; Langer C; Redman R; Pajak TF; Fleming TR; Henke M; Bourhis J; Rosenthal DI; Junor E; Cmelak A; Sheehan F; Pulliam J; Devitt-Risse P; Fuchs H; Chambers M; O'Sullivan B; Ang KK
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):674-81. PubMed ID: 14967419
[TBL] [Abstract][Full Text] [Related]
3. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study.
Aghamohammadi A; Moslemi D; Akbari J; Ghasemi A; Azadbakht M; Asgharpour A; Hosseinimehr SJ
Clin Oral Investig; 2018 Jul; 22(6):2263-2272. PubMed ID: 29313134
[TBL] [Abstract][Full Text] [Related]
5. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.
Lozano A; Marruecos J; Rubió J; Farré N; Gómez-Millán J; Morera R; Planas I; Lanzuela M; Vázquez-Masedo MG; Cascallar L; Giralt J; Escames G; Valentí V; Grima P; Bosser R; Tarragó C; Mesía R
Clin Transl Oncol; 2021 Sep; 23(9):1801-1810. PubMed ID: 33738704
[TBL] [Abstract][Full Text] [Related]
6. Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial.
Sio TT; Le-Rademacher JG; Leenstra JL; Loprinzi CL; Rine G; Curtis A; Singh AK; Martenson JA; Novotny PJ; Tan AD; Qin R; Ko SJ; Reiter PL; Miller RC
JAMA; 2019 Apr; 321(15):1481-1490. PubMed ID: 30990550
[TBL] [Abstract][Full Text] [Related]
7. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
El-Sayed S; Nabid A; Shelley W; Hay J; Balogh J; Gelinas M; MacKenzie R; Read N; Berthelet E; Lau H; Epstein J; Delvecchio P; Ganguly PK; Wong F; Burns P; Tu D; Pater J
J Clin Oncol; 2002 Oct; 20(19):3956-63. PubMed ID: 12351592
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt & soda mouthwashes.
Dodd MJ; Miaskowski C; Greenspan D; MacPhail L; Shih AS; Shiba G; Facione N; Paul SM
Cancer Invest; 2003; 21(1):21-33. PubMed ID: 12643006
[TBL] [Abstract][Full Text] [Related]
10. Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study.
Saarilahti K; Kajanti M; Joensuu T; Kouri M; Joensuu H
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):479-85. PubMed ID: 12243825
[TBL] [Abstract][Full Text] [Related]
11. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Epstein JB; Silverman S; Paggiarino DA; Crockett S; Schubert MM; Senzer NN; Lockhart PB; Gallagher MJ; Peterson DE; Leveque FG
Cancer; 2001 Aug; 92(4):875-85. PubMed ID: 11550161
[TBL] [Abstract][Full Text] [Related]
12. Sumac-rose water mouthwash versus benzydamine to prevent radiation-induced oral mucositis in head and neck cancers: a phase II randomized trial.
Ameri A; Heydarirad G; Choopani R; Poshtmahi S; Ameri P; Talebi F; Bagheri Pour A; Taghizadeh-Hesary F
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7427-7439. PubMed ID: 36947237
[TBL] [Abstract][Full Text] [Related]
13. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.
Lalla RV; Choquette LE; Curley KF; Dowsett RJ; Feinn RS; Hegde UP; Pilbeam CC; Salner AL; Sonis ST; Peterson DE
Oral Oncol; 2014 Nov; 50(11):1098-103. PubMed ID: 25151488
[TBL] [Abstract][Full Text] [Related]
14. Results of a randomized controlled phase III trial: efficacy of polyphenol-containing cystus® tea mouthwash solution for the reduction of mucositis in head and neck cancer patients undergoing external beam radiotherapy.
Ebert N; Kensche A; Löck S; Hadiwikarta WW; Hänsch A; Dörr W; Krause M; Hannig C; Baumann M
Strahlenther Onkol; 2021 Jan; 197(1):63-73. PubMed ID: 32970162
[TBL] [Abstract][Full Text] [Related]
15. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of Oral Mucositis with Iodine Solution during Concurrent Chemoradiation of Head and Neck Cancer: Preliminary Results of a Double-Blind, Randomized Controlled Trial.
Namuangchan Y; Chailertwanich O; Susinsamphan S; Supakalin N; Supaadirek C; Krusun S; Pesee M; Thamronganantasakul K
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2445-2454. PubMed ID: 37505779
[TBL] [Abstract][Full Text] [Related]
17. Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer.
Bensadoun RJ; Franquin JC; Ciais G; Darcourt V; Schubert MM; Viot M; Dejou J; Tardieu C; Benezery K; Nguyen TD; Laudoyer Y; Dassonville O; Poissonnet G; Vallicioni J; Thyss A; Hamdi M; Chauvel P; Demard F
Support Care Cancer; 1999 Jul; 7(4):244-52. PubMed ID: 10423050
[TBL] [Abstract][Full Text] [Related]
18. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study.
Makkonen TA; Boström P; Vilja P; Joensuu H
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):177-82. PubMed ID: 8083112
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: A double-blind placebo-controlled randomized clinical trial.
Sheibani KM; Mafi AR; Moghaddam S; Taslimi F; Amiran A; Ameri A
Asia Pac J Clin Oncol; 2015 Mar; 11(1):22-7. PubMed ID: 25471468
[TBL] [Abstract][Full Text] [Related]
20. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
Anderson CM; Lee CM; Saunders DP; Curtis A; Dunlap N; Nangia C; Lee AS; Gordon SM; Kovoor P; Arevalo-Araujo R; Bar-Ad V; Peddada A; Colvett K; Miller D; Jain AK; Wheeler J; Blakaj D; Bonomi M; Agarwala SS; Garg M; Worden F; Holmlund J; Brill JM; Downs M; Sonis ST; Katz S; Buatti JM
J Clin Oncol; 2019 Dec; 37(34):3256-3265. PubMed ID: 31618127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
